Not recruiting
Non-Hodgkin's lymphoma+13
Not recruitingStudy of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials
InvestigationalNo placebo
Study of Long-term Safety of Tazemetostat in Patients Who Previously Participated in Tazemetostat Clinical Trials
InvestigationalNo placebo
- Disease:Non-Hodgkin's lymphomaLimb reduction defect+12
- Substances:Tazemetostat
Countries:
France
France- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Tazemetostat
- Sponsor:Epizyme Inc.

